ReviewCardiologyImmunologyNephrology Open Access | 10.1172/JCI197141 Published in Volume 136, Issue 1 on January 2, 2026 J Clin Invest. 2026;136(1):e197141. https://doi.org/10.1172/JCI197141. © 2026 Reiser et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jochen Reiser
Guest commentary: Lawmakers made wise health care investments during recent session
On June 2 or “Sine Die,” Texas legislators departed from Austin to return to their hometowns across the state, signaling that the 89th Legislative Session had come to a close. This session was my first opportunity to represent the University of Texas Medical Branch in my role as president, which I began in August 2023.
XOR risk variants drive diabetic kidney disease - Nature Metabolism
Cite this article Zhu, K., Reiser, J. XOR risk variants drive diabetic kidney disease. Nat Metab (2023). https://doi.org/10.1038/s42255-023-00768-0 Download citation Published: 06 April 2023 DOI: https://doi.org/10.1038/s42255-023-00768-0 Share this article Anyone you share the following link with will be able to read this content: Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative Subjects
SARS-CoV-2 pirates the kidneys: A scar(y) story
SARS-CoV-2 can cause diverse severe and lasting damage to the kidneys. In the latest issue of Cell Stem Cell, Jansen et al. utilized data gleaned from human kidney autopsies and human induced pluripotent stem cell-derived kidney organoids to investigate the direct effects of SARS-CoV-2 infection on kidney cells. They found that such infections resulted in renal scarring (notably, tubulointerstitial fibrosis).
Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease
Steps for Creating an Account: Click the "Purchase Access" button. The page will redisplay with the following message at the top of the screen which contains the link to register for an account. When you create an account, you will be asked for your name, email address and other information. Just like commercial web sites, we do need details from you in order to complete your purchase of an article.
More expression, less function: cleaved dynamin in glomerular kidney disease
The role of dynamin in regulation of kidney filtration barrier is well documented. Dynamin binds to and produces filamentous actin, which is a key component of healthy podocyte foot processes. Destruction of dynamin, for example by cathepsin L, leads to loss of a functional actin network and uncoordinated membrane signaling, a situation that allows for effacement of foot processes and proteinuria. Now, Khalil et al.
An Early Warning Sign for Chronic Kidney Disease
Elevated levels of soluble urokinase-type plasminogen activator receptor (suPAR) are associated with poor outcomes. Chronic kidney disease (CKD) and progressive loss of kidney function affects about 11% of all Americans and put patients at higher risk for cardiovascular disease (CVD) and death. Screening for kidney disease is limited in that we rely on measuring urinary protein excretion and calculating estimated glomerular filtration rates (eGFRs).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jochen
Contact Jochen, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack